Daniel Arias
Stock Analyst at Stifel Nicolaus
(4.32)
# 1,351
Out of 5,022 analysts
521
Total ratings
49%
Success rate
8.1%
Average return
Main Sectors:
Stocks Rated by Daniel Arias
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TMO Thermo Fisher Scientific | Maintained: Buy | n/a | $641.39 | - | 34 | Sep 16, 2026 | |
| RGEN Repligen | Maintained: Buy | n/a | $174.73 | - | 33 | Sep 16, 2026 | |
| ILMN Illumina | Reiterated: Buy | $225 | $222.29 | +1.22% | 50 | Sep 15, 2026 | |
| A Agilent Technologies | Reiterated: Buy | $180 | $150.27 | +19.78% | 28 | Aug 30, 2026 | |
| MXCT MaxCyte | Reiterated: Buy | $4 | $1.19 | +236.13% | 17 | Aug 13, 2026 | |
| MASS 908 Devices | Reiterated: Buy | $10 → $12 | $9.97 | +20.36% | 17 | Aug 12, 2026 | |
| ALMR Alamar Biosciences | Reiterated: Buy | $28 → $32 | $28.75 | +11.30% | 3 | Aug 11, 2026 | |
| MRVI Maravai LifeSciences Holdings | Reiterated: Buy | $6 → $8 | $6.88 | +16.28% | 25 | Aug 11, 2026 | |
| QGEN Qiagen | Reiterated: Hold | $40 | $42.48 | -5.84% | 21 | Aug 11, 2026 | |
| TXG 10x Genomics | Reiterated: Buy | $50 | $74.39 | -32.79% | 26 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $1.15 | +595.65% | 7 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $145 | $104.27 | +39.06% | 4 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $45 → $50 | $55.75 | -10.31% | 24 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $100 → $110 | $140.19 | -21.54% | 29 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $380 → $420 | $417.09 | +0.70% | 29 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $130 → $180 | $175.65 | +2.48% | 18 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1,400 → $1,600 | $1,330.40 | +20.26% | 30 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $60 → $50 | $68.85 | -27.38% | 12 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $8 → $15 | $15.44 | -2.85% | 19 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $260 → $220 | $209.36 | +5.08% | 27 | Jul 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $65 → $50 | $72.34 | -30.88% | 28 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $1.40 | +257.14% | 18 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $7.94 | n/a | 9 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $4.17 | n/a | 13 | Mar 1, 2024 |
Thermo Fisher Scientific
Sep 16, 2026
Maintained: Buy
Price Target: n/a
Current: $641.39
Upside: -
Repligen
Sep 16, 2026
Maintained: Buy
Price Target: n/a
Current: $174.73
Upside: -
Illumina
Sep 15, 2026
Reiterated: Buy
Price Target: $225
Current: $222.29
Upside: +1.22%
Agilent Technologies
Aug 30, 2026
Reiterated: Buy
Price Target: $180
Current: $150.27
Upside: +19.78%
MaxCyte
Aug 13, 2026
Reiterated: Buy
Price Target: $4
Current: $1.19
Upside: +236.13%
908 Devices
Aug 12, 2026
Reiterated: Buy
Price Target: $10 → $12
Current: $9.97
Upside: +20.36%
Alamar Biosciences
Aug 11, 2026
Reiterated: Buy
Price Target: $28 → $32
Current: $28.75
Upside: +11.30%
Maravai LifeSciences Holdings
Aug 11, 2026
Reiterated: Buy
Price Target: $6 → $8
Current: $6.88
Upside: +16.28%
Qiagen
Aug 11, 2026
Reiterated: Hold
Price Target: $40
Current: $42.48
Upside: -5.84%
10x Genomics
Aug 11, 2026
Reiterated: Buy
Price Target: $50
Current: $74.39
Upside: -32.79%
Aug 10, 2026
Reiterated: Buy
Price Target: $8
Current: $1.15
Upside: +595.65%
Aug 6, 2026
Reiterated: Buy
Price Target: $145
Current: $104.27
Upside: +39.06%
Aug 5, 2026
Reiterated: Hold
Price Target: $45 → $50
Current: $55.75
Upside: -10.31%
Aug 5, 2026
Rated: Hold
Price Target: $100 → $110
Current: $140.19
Upside: -21.54%
Aug 5, 2026
Rated: Hold
Price Target: $380 → $420
Current: $417.09
Upside: +0.70%
Aug 3, 2026
Reiterated: Buy
Price Target: $130 → $180
Current: $175.65
Upside: +2.48%
Aug 3, 2026
Reiterated: Buy
Price Target: $1,400 → $1,600
Current: $1,330.40
Upside: +20.26%
Aug 3, 2026
Reiterated: Hold
Price Target: $60 → $50
Current: $68.85
Upside: -27.38%
Jul 30, 2026
Rated: Hold
Price Target: $8 → $15
Current: $15.44
Upside: -2.85%
Jul 22, 2026
Reiterated: Buy
Price Target: $260 → $220
Current: $209.36
Upside: +5.08%
May 7, 2026
Reiterated: Hold
Price Target: $65 → $50
Current: $72.34
Upside: -30.88%
Nov 10, 2025
Reiterated: Buy
Price Target: $5
Current: $1.40
Upside: +257.14%
Jan 22, 2025
Rated: Hold
Price Target: n/a
Current: $7.94
Upside: n/a
Mar 1, 2024
Reiterated: Buy
Price Target: $5
Current: $4.17
Upside: n/a